Sindrome.del.Ovario.Poliquistico

162 Síndrome del Ovario Poliquístico
29
Daya S. GnRH agonists versus antagonist
in assisted reproduction-a systematic
review. In: Kenes. Libro de Ponencias
del 8 th Symposium GnRH analogues in
cancer and Human reproduction. Salzburgo,
Austria; 2005 Feb 10.
30
Olivennes F, Cunha-Filho JS, Fanchin
R, Bouchard P, Frydman R. The use
of GnRH antagonists in ovarian stimulation.
Hum Reprod Update. 2002;8:
279-90.
31
Reissmann T, Felberbaum R, Diedrich
K, Engel J, Comaru-Schally AM, Schally
AV. Development and applications of
luteinizing hormone-releasing hormone
antagonists in the treatment of infertility:
an overview. Hum Reprod. 1995;10:
1974-81.
32
Fauser BC, De Jong D, Olivennes F,
Wramsby H, Tay C, Itskovitz-Eldor J,
et al. Endocrine profiles after triggering
of final oocyte maturation with
GnRH agonist after cotreatment with
the GnRH antagonist ganirelix during
ovarian hyperstimulation for in vitro
fertilization. J Clin Endocrinol Metab.
2002;87:709-15.
33
Itskovitz-Eldor J, Kol S, Mannaerts B.
Use of a single bolus of GnRH agonist
triptorelin to trigger ovulation after
GnRH antagonist ganirelix treatment in
women undergoing ovarian stimulation
for assisted reproduction, with special
reference to the prevention of ovarian
hyperstimulation syndrome: preliminary
report: short communication. Hum
Reprod. 2000;15:1965-8.
34
Fatemi HM, Platteau P, Albano C, Van
Steirteghem A, Devroey P. Rescue IVF
and coasting with the use of a GnRH
antagonist after ovulation induction.
Reprod Biomed Online. 2002;5:273-5.
35
Al-Inany H, Aboulghar M. GnRH antagonist
in assisted reproduction: a Cochrane
review. Hum Reprod. 2002;17:874-85.
36
Escudero E, Bosch E, Crespo J, Simón C,
Remohí J, Pellicer A. Comparison of two
different starting multiple dose gonadotropin-releasing
hormone antagonist
protocols in a selected group of in vitro
fertilization-embryo transfer patients.
Fertil Steril. 2004;81:562-6.
37
Requena A, Giles J, Martínez-Salazar J,
García-Velasco JA. Uso de los antagonistas
de la GnRH en un protocolo de
estimulación para FIV en pacientes con
síndrome de ovario poliquístico. Rev
Iberoam Fertil. 2003;20:15-9.
38
Kolibianakis E, Zikopoulos K, Albano
C, Camus M, Tournaye H, Van Steirteghem
A, et al. Reproductive outcome of
polycystic ovarian syndrome patients
treated with GnRH antagonists and
recombinant FSH for IVF/ICSI. Reprod
Biomed Online. 2003;7:313-8.
39
Requena A, Giles J, García-Velasco JA,
Remohí J. Empleo del antagonista de
la GnRH en pacientes con síndrome de
ovario poliquístico estimulados para un
ciclo de Reproducción Asistida. Reprod
Hum. 2003;3:25-31.
40
Corona J, Requena A, De Pablo JL,
García-Velasco JA. GnRH antagonist in
oocyte donation: a matched cas-control
study. Hum Reprod. 2003;18(Suppl 1):
106.
41
Urman B, Tiras B, Yakin K. Assisted
reproduction in the treatment of polycystic
ovarian syndrome. Reprod Biomed
Online. 2004;8:419-30.
42
Marci R, Senn A, Dessole S, Chanson
A, Loumaye E, De Grandi P, et al. A
low-dose stimulation protocol using
highly purified follicle-stimulating hormone
can lead to high pregnancy rates
in in vitro fertilization patients with
polycystic ovaries who are at risk of a
high ovarian response to gonadotropins.
Fertil Steril. 2001;75:1131-5.
43
Inaudi P, Reymond MJ, Rey F, Genazzani
AD, Lemarchand-Beraud T. Pulsatile
secretion of gonadotropins and prolactin
during the follicular and luteal phases
of the menstrual cycle: analysis of
instantaneous secretion rate and secretory
concomitance. Fertil Steril. 1992;58:
51-9.